Rijneveld AW - Search Results

1

Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.

Schultz MJ, Rijneveld AW, Florquin S, Speelman P, VAN Deventer SJH, VAN DER Poll T. Schultz MJ, et al. Among authors: rijneveld aw. J Med Microbiol. 2001 Sep;50(9):822-827. doi: 10.1099/0022-1317-50-9-822. J Med Microbiol. 2001. PMID: 11549184

2

The role of interferon-gamma in murine pneumococcal pneumonia.

Rijneveld AW, Lauw FN, Schultz MJ, Florquin S, Te Velde AA, Speelman P, Van Deventer SJ, Van Der Poll T. Rijneveld AW, et al. J Infect Dis. 2002 Jan 1;185(1):91-7. doi: 10.1086/338122. Epub 2001 Dec 14. J Infect Dis. 2002. PMID: 11756986

3

Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice.

Rijneveld AW, van den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, van Alphen L, van der Poll T. Rijneveld AW, et al. J Infect Dis. 2002 Jan 1;185(1):123-6. doi: 10.1086/338008. Epub 2001 Nov 30. J Infect Dis. 2002. PMID: 11756992

4

Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia.

Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, van der Poll T. Schultz MJ, et al. Among authors: rijneveld aw. Am J Physiol Lung Cell Mol Physiol. 2002 Feb;282(2):L285-90. doi: 10.1152/ajplung.00461.2000. Am J Physiol Lung Cell Mol Physiol. 2002. PMID: 11792633 Free article.

5

Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.

Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van Der Poll T. Rijneveld AW, et al. J Immunol. 2002 Apr 1;168(7):3507-11. doi: 10.4049/jimmunol.168.7.3507. J Immunol. 2002. PMID: 11907112

6

Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T. Rijneveld AW, et al. J Infect Dis. 2004 Feb 15;189(4):711-6. doi: 10.1086/381392. Epub 2004 Jan 30. J Infect Dis. 2004. PMID: 14767826

7

TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.

Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T. Rijneveld AW, et al. J Immunol. 2001 Nov 1;167(9):5240-6. doi: 10.4049/jimmunol.167.9.5240. J Immunol. 2001. PMID: 11673538

8

Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia.

Schultz MJ, Rijneveld AW, Speelman P, van Deventer SJ, van der Poll T. Schultz MJ, et al. Among authors: rijneveld aw. Eur Cytokine Netw. 2001 Mar;12(1):39-44. Eur Cytokine Netw. 2001. PMID: 11282544 Free article.

9

Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia.

Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Levi M, et al. Among authors: rijneveld aw. Crit Care Med. 2003 Apr;31(4 Suppl):S238-42. doi: 10.1097/01.CCM.0000057849.53689.65. Crit Care Med. 2003. PMID: 12682446 Review.

10

Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia.

Rijneveld AW, Florquin S, Bresser P, Levi M, De Waard V, Lijnen R, Van Der Zee JS, Speelman P, Carmeliet P, Van Der Poll T. Rijneveld AW, et al. Blood. 2003 Aug 1;102(3):934-9. doi: 10.1182/blood-2003-01-0227. Epub 2003 Apr 17. Blood. 2003. PMID: 12702502 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters